One study reported the effectiveness of anti-TNFα antibody in the amelioration of DKD in Ins2Akita diabetic mice and protection from streptozocin-treated hyperglycemic kidney injury in another macrophage-specific TNFα-deficient mice model. This evidence concerns the gene TNF and diabetic kidney disease.